Diagnostik, Prothesen, Impfstoffe, Genomik: die Medizin, die Lebensjahre gewinnt.
Medizin, die Lebensjahre gewinnt: KI-gestützte Vorsorge, die Millionen Patienten untersucht, Impfstoffe der neuen Generation, Genomik auf dem Weg von der Sequenzierung zur Therapie, Prothesen und Implantate, die verlorene Fähigkeiten zurückgeben. Die Rubrik verfolgt abgeschlossene klinische Studien, Marktzulassungen, Einführungen in Kliniken — den Moment, in dem eine Technologie aufhört, ein Paper zu sein, und zur Versorgung wird.
Die Zahlen entscheiden: Kohorten, Erkennungsraten, vermiedene Sterblichkeit, Kosten. Wir berichten gern über Gesundheitssysteme, die im großen Maßstab einführen — Indien, Brasilien, Südostasien —, weil sich sparsame Technologien oft dort bewähren, bevor sie anderswo ankommen. Jeder Artikel stützt sich auf die Studie, die Zulassung oder die Untersuchung dahinter — und nennt sie.
The TPMS design was developed by Bettina Wiegmann’s team at Hannover Medical School with RWTH Aachen researchers.
The figure came from women who received the program as intended, versus 49.9% with usual care.
Imaging reveals a right-twisting inner layer inside a left-twisting outer layer.
A 205-patient cohort found lower serum urea, phosphate and potassium with protein prescriptions of ≤0.6 g/kg/day.
More than 3,300 adults were analyzed across Ghana, Nigeria, Kenya and Europe.
The test uses an extra four microliters of blood and returns a result in 10–20 minutes.
A citrus flavonoid shifted old mice’s liver activity toward a younger profile.
WashU researchers found lymph node-like structures in the skull marrow of mice and evidence of similar cells in humans.
Indigo light is abundant in sunlight but scarce in standard white LED lighting.
IOCAS researchers linked an oyster energy-stress pathway to glycolysis in human lung adenocarcinoma cells.
The 9D5 antibody protected mice from lethal CCHFV infection and recognized a protein shared across several virus strains.
The pattern appeared in three datasets covering 2,616 colorectal tumors.
GT19630 targets MYC and GSPT1 together in leukemia, lymphoma and multiple myeloma models.
The study involved 22 people in brain imaging and 20 in magnetic stimulation experiments.
A randomized pilot tested daily 20 mg of zinc in 100 Ugandan children aged 1 to 5.
Teams in Australia and Hong Kong tracked nutrients from cell organelles into newly formed bone.
University of Michigan researchers combined BET and DNMT inhibitors against prostate tumors that had changed cellular identity.
The case involved one patient whose treatment-resistant lung tumor disappeared after a treatment protocol involving selenite and chemotherapy.